Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: Colestipol and clofibrate
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 32 (8) , 818-821
- https://doi.org/10.1016/0026-0495(83)90113-0
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Clofibrate Effect on Alkaline Phosphatase: Bone or Liver FractionNew England Journal of Medicine, 1977
- Clofibrate Effect on Alkaline Phosphatase in Renal FailureNew England Journal of Medicine, 1977
- Reduction of Serum Alkaline Phosphatase and Gamma-Glutamyl Transpeptidase Activities by Short-Term ClofibrateNew England Journal of Medicine, 1976
- REDUCTION OF SERUM-ALKALINE- PHOSPHATASE BY CLOFIBRATEThe Lancet, 1975
- Colestipol and clofibrate in hypercholesterolemiaClinical Pharmacology & Therapeutics, 1974
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Dietary and Drug Treatment of Primary HyperlipoproteinemiaAnnals of Internal Medicine, 1972
- Comparative clinical therapeutic trial with two hypolipidemic drugs: Clofibrate and nafenopinClinical Pharmacology & Therapeutics, 1971
- Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and manAtherosclerosis, 1970
- Reduction of Cholesterol and Lipids in Man by Ethyl p-ChlorophenoxyisobutyrateAnnals of Internal Medicine, 1963